Wakix Hits Record High Prescription Demand in Q2

Harmony Biosciences Holdings Inc reported second-quarter business updates, showcasing an upswing in prescription demand for its narcolepsy drug, Wakix.  Second-quarter growth was up 25% versus the same period in 2022, primarily attributed to strong commercial sales of Wakix driven by continued organic demand tapping into a large market opportunity (approximately 80,000 patients are diagnosed with…

Read More

Membership at Metropolitan Tabernacle: Church Polity with Charles Spurgeon

ABSTRACT: Throughout Charles Spurgeon’s decades of ministry, more than 14,000 people sought to join the church he pastored. Rather than rushing them into membership, however, Spurgeon and the other pastors at the Metropolitan Tabernacle patiently shepherded applicants through a five-part process. Along the way, Spurgeon engaged not only a plurality of pastors but also the…

Read More

Series of Regulatory Developments Define Inspire’s Q2 Landscape

Inspire Medical Systems Inc, a medical technology company focused on the development of solutions for patients with obstructive sleep apnea, reported second-quarter business results, marked by a series of US Food and Drug Administration (FDA) regulatory approvals and submissions. During the quarter, Inspire received FDA approval for apnea-hypopnea index indication expansion and increased body mass…

Read More

How Social Jet Lag Is Harming Gut Health

Irregular sleep patterns—oftentimes caused by social jet lag—are associated with harmful bacteria in your gut, according to new research published in The European Journal of Nutrition. The study by researchers from King’s College London and ZOE, a personalized nutrition company, finds multiple associations between social jet lag—the shift in your internal body clock when your…

Read More